Meta-DOT

Meta-DOT
Clinical data
Other names5-Methylthio-2,4-dimethoxyamphetamine; 2,4-Dimethoxy-5-methylthioamphetamine
Routes of
administration		Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • 1-[2,4-dimethoxy-5-(methylsulfanyl)phenyl]propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H19NO2S
Molar mass241.35 g·mol−1
3D model (JSmol)
  • O(c1cc(OC)c(cc1SC)CC(N)C)C
  • InChI=1S/C12H19NO2S/c1-8(13)5-9-6-12(16-4)11(15-3)7-10(9)14-2/h6-8H,5,13H2,1-4H3 Y
  • Key:BEMIKIUJWHLJTP-UHFFFAOYSA-N Y
  (verify)

Meta-DOT, also known as 5-methylthio-2,4-dimethoxyamphetamine, is a drug.[1] It is similar in structure to TMA-2.[1] Meta-DOT was first synthesized by Alexander Shulgin.[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dose is listed as 35 mg, and the duration unknown.[1] Meta-DOT produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of Meta-DOT.[1]

See also

References

  1. ^ a b c d e f g h Alexander Shulgin. "PiHKAL".
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.